Cape Verde Health Regulator Warns Against Unlicensed Skin Treatments
The ERIS (entity responsible for health regulation and inspection in Cape Verde) has issued a warning on March 8th regarding skin treatments performed in unlicensed salons. ERIS emphasizes that procedures with a therapeutic purpose, aimed at treating conditions like acne and melasma, must be conducted by qualified healthcare professionals in licensed health facilities, not in aesthetic establishments without authorization. The regulator notes that beauty salons are promoting and performing treatments for dermatological conditions, which are recognized by the scientific community and classified by the World Health Organization (WHO) as skin diseases or disorders. ERIS clarifies that any procedure intended to prevent, diagnose, treat, control, or alleviate a disease or clinical condition transcends simple aesthetics and falls under healthcare provision. Consequently, treatments for skin pathologies using specialized equipment, chemicals, invasive techniques, or therapeutic protocols require licensed healthcare providers and facilities. The circular highlights risks from unqualified individuals or unauthorized locations, including burns, infections, adverse reactions, disease exacerbation, permanent scarring, pigmentation changes, and delayed diagnosis. ERIS advises users to verify professional qualifications, facility licensing, and clinical assessment before undergoing skin disease treatments. They also recommend researching procedure risks and contraindications, checking hygiene standards, and avoiding invasive interventions in unsafe settings. Individuals with active medical conditions should seek prior medical advice, and immediate medical attention is necessary for complications like infections or severe lesions. ERIS pledges to monitor the situation and take necessary actions to protect public health and user rights. Acne is described as an inflammatory skin disease causing various lesions due to clogged hair follicles, while melasma is a pigmentation disorder causing symmetrical brown patches, often triggered by sun exposure, hormones, and genetics.
The ERIS's directive underscores a critical public health concern: the blurring lines between aesthetic services and medical treatments. By clarifying that procedures addressing recognized skin diseases, regardless of their presentation, constitute healthcare, ERIS aims to mitigate risks stemming from unqualified practitioners and unregulated environments. This regulatory stance highlights the systemic challenge of ensuring patient safety when commercial interests in the beauty sector may incentivize bypassing established medical protocols. Moving forward, a key consideration will be the enforcement mechanisms available to ERIS and the industry's response to these guidelines. The potential for AI-driven diagnostic tools and personalized treatment plans in dermatology also presents future complexities, requiring robust regulatory frameworks that can adapt to technological advancements while prioritizing patient well-being and preventing the exploitation of vulnerable consumers.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.